Latest Board Changes News

Redox enters FY27 from a position of record revenue, higher margins and a debt-free balance sheet, while its North American business passes $100 million in sales. The chemical distributor also reported 9% higher average selling prices in the first quarter, although volumes remained broadly flat and freight costs increased.

High-Tech Metals has installed a new leadership team and arranged an 11.9% share crossing as it shifts focus from exploration to production at its Western Australian gold projects. The strategy is backed by approximately A$9 million in cash, but still depends on studies, approvals and shareholder decisions.

Being AI is preparing to transfer 57% of its issued shares to existing shareholders while moving a 14.4% stake to Excalibur Capital Partners. The transactions are due to complete on 12 October, when the company will also receive a new chair and board.

Embark Early Education has requested a general meeting to install its chair and managing director on Mayfield Childcare’s board and remove three directors. The move comes after Embark lifted its stake in Mayfield to 50.04%, raising the prospect of a board with no directors independent of the majority shareholder.

Chimeric Therapeutics remains suspended from ASX trading after failing to lodge its FY2026 financial statements, with the company reporting an approximate $7.7 million net asset deficiency and unresolved creditor negotiations. Potential recapitalisation interest has emerged, but no binding funding or settlement agreement has been reached.

Xamble has appointed Adrian Tan permanent CEO and elevated Georg Johann Chmiel to chair as it seeks to convert recent operating improvements into sustained growth. Ganesh Kumar Bangah is stepping down from the board to take a senior Malaysian government-linked role but will remain involved as an adviser and substantial shareholder.

Booster has secured a further $7.4 million capital commitment for the Booster Innovation Fund, taking total committed and allocated capital above $23 million. The funding announcement arrives alongside disclosure of civil proceedings by New Zealand’s Financial Markets Authority and a new independent director.

Australian Bond Exchange Holdings improved revenue, reduced its annual loss and sharply cut operating cash outflow in FY2026. Yet with only A$249,000 in cash, net liabilities of A$1.43 million and A$2 million of convertible notes maturing from April 2027, the turnaround remains financially fragile.

Quay Global’s two real estate funds delivered sharply different FY2026 results, with the unhedged fund swinging to a $22.852 million operating loss while the AUD Hedged fund recorded a $22.991 million profit. The year also brought large ETF redemptions, new currency-hedging disclosures and a major reset of Bennelong’s board after year-end.

Pengana International Equities has cancelled 151.1 million shares in a $183.28 million buy-back, leaving a much smaller listed investment company and three fewer directors. The reconstituted board will review capital options before deciding whether to pursue a future rights issue.

G50 Corp has moved from early-stage exploration towards a two-project drilling campaign, backed by a post-year-end A$26.25 million placement. The company remains loss-making and reliant on exploration success, but says the capital allows uninterrupted work at its Arizona and Nevada projects.

Memphasys will receive an A$3.5 million advance from major shareholder Peters Investments to expand Felix production, inventory and sales capacity as repeat orders emerge across international markets. The funding carries a 12.5% interest rate, potential equity dilution and requires shareholder and ASX approvals before the convertible notes can be issued.